pyrroles has been researched along with pyruvic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| GOTTSCHALK, A | 1 |
| Gregus, Z; Németi, B | 1 |
| Akiyama, T; Itoh, J; Kashikura, W; Mori, K | 1 |
| Devasahayam, N; Krishna, MC; Lizak, MJ; Matsumoto, S; Matsuo, M; Merkle, H; Mitchell, JB; Morris, HD; Munasinghe, JP; Saito, K; Suburamanian, S; Takakusagi, Y; Yasukawa, K | 1 |
| Boison, D; Chen, QY; Gao, J; Lu, NN; Weng, ZY; Xiao, XX | 1 |
| Hu, K; Huang, J; Jiang, R; Li, L; Lin, L; Lv, X; Shen, Y; Tang, L; Wan, J; Yang, Y; Zhang, L; Zhou, H | 1 |
| Hao, D; Liu, X; Wang, X; Wang, Z; Yu, J | 1 |
7 other study(ies) available for pyrroles and pyruvic acid
| Article | Year |
|---|---|
The synthesis of 2-carboxypyrrole from D-glucosamine and pyruvic acid: its bearing on the structure of neuraminic acid.
Topics: Amino Acids; Biochemical Phenomena; Glucosamine; Neuraminic Acids; Pyrroles; Pyruvates; Pyruvic Acid | 1957 |
Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
Topics: Arsenates; Arsenite Transporting ATPases; Blood Glucose; Dithiothreitol; Erythrocytes; Ferricyanides; Glucose Oxidase; Glutathione; Humans; In Vitro Techniques; Inosine; Ion Pumps; Multienzyme Complexes; NADP; Oxidation-Reduction; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Pyruvic Acid; Spectrophotometry, Atomic | 2004 |
Enantioselective Friedel-Crafts alkylation of indoles, pyrroles, and furans with trifluoropyruvate catalyzed by chiral phosphoric acid.
Topics: Alkylation; Catalysis; Furans; Heterocyclic Compounds; Hydrocarbons, Fluorinated; Indoles; Organic Chemistry Phenomena; Phosphoric Acids; Pyrroles; Pyruvic Acid; Stereoisomerism | 2010 |
In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Contrast Media; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Female; Humans; Indoles; Magnetic Resonance Imaging; Mice, Inbred C3H; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Oxidation-Reduction; Oxygen; Pyrroles; Pyruvic Acid; Sunitinib; Xenograft Model Antitumor Assays | 2014 |
Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Hep G2 Cells; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Neoplasms; Pyrroles; Pyruvic Acid | 2016 |
Activation of PKM2 metabolically controls fulminant liver injury via restoration of pyruvate and reactivation of CDK1.
Topics: Animals; Apoptosis; CDC2 Protein Kinase; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Pyridazines; Pyrroles; Pyruvate Kinase; Pyruvates; Pyruvic Acid | 2021 |
Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells.
Topics: Biomarkers; Diabetic Nephropathies; ErbB Receptors; Glucose; Humans; MicroRNAs; Pyridazines; Pyrroles; Pyruvate Kinase; Pyruvic Acid; Transcriptome; Tumor Suppressor Protein p53 | 2022 |